[1] Siegel R,Naishadham D,Jemal A.Cancer statistics,2012[J].Cancer J Clin,2012,62(1):10-29.DOI:10.3322/caac.20138.
[2] Jacobs NL,Que FG,Miller RC,et al. Cumulative morbidity and late mortality in long-term survivors of exocrine pancreas cancer[J].J Gastrointest Cancer,2009,40(1-2):46-50.DOI:10.1007/s12029-009-9082-y.
[3] Spinelli GP,Zullo A,Romiti A,et al. Long-term survival in metastatic pancreatic cancer. A case report and review of the literature[J].JOP,2006,7(5):486-491.
[4] Li DH,Xie KP,Wolff R,et al. Pancreatic cancer[J].Lancet,2004,363(9414):1049-1057.DOI:10.1016/S0140-6736(04)15841-8.
[5] Gregory RI,Chendrimada TP,Cooch N,et al. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing[J].Cell,2005,123(4):631-640.DOI:10.1016/j.cell.2005.10.022.
[6] Lai EC.Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation[J].Nat Genet,2002,30(4):363-364.DOI:10.1038/ng865.
[7] Calin GA,Croce CM.MicroRNA signatures in human cancers[J].Nat Rev Cancer,2006,6(11):857-866.DOI:10.1038/nrc1997.
[8] Croce CM.Causes and consequences of microRNA dysregulation in cancer[J].Nat Rev Genet,2009,10(10):704-714.DOI:10.1038/nrg2634.
[9] Ueda T,Volinia S,Okumura H,et al. Relation between microRNA expression and progression and prognosis of gastric cancer:a microRNA expression analysis[J].Lancet Oncol,2010,11(2):136-146.DOI:10.1016/S1470-2045(09)70343-2.
[10] Gallinas SC,Lizé M.MIR449A (microRNA 449a)[J].Atlas Genet Cytogenet Oncol Haematol,2013,17(3):188-192.
[11] Zhang YH,Wang QQ,Li H,et al.miR-124 radiosensitizes human esophageal cancer cell TE-1 by targeting CDK4[J].Genet Mol Res,2016,15(2).DOI:10.4238/gmr.15027893.
[12] Song L,Liu S,Zhang L,et al. MiR-21 modulates radiosensitivity of cervical cancer through inhibiting autophagy via the PTEN/Akt/HIF-1α feedback loop and the Akt-mTOR signaling pathway[J].Tumor Biol,2016,37(9):12161-12168.DOI:10.1007/s13277-016-5073-3.
[13] Liu G,Li Y,Gao X.Overexpression of microRNA-133b sensitizes non-small cell lung cancer cells to irradiation through the inhibition of glycolysis[J].Oncol Lett,2016,11(4):2903-2908.DOI:10.3892/ol.2016.4316.
[14] Mao AH,Zhao QY,Zhou X,et al. MicroRNA-449a enhances radiosensitivity by downregulation of c-Myc in prostate cancer cells[J].Sci Rep,2016,6:27346.DOI:10.1038/srep27346.
[15] Mao AH,Liu Y,Wang YL,et al.miR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells[J].Tumor Biol,2016,37(4):4831-4840.
[16] Liu YJ,Lin YF,Chen YF,et al. MicroRNA-449a enhances radiosensitivity in CL1-0 lung adenocarcinoma cells[J].PLoS One,2013,8(4):e62383.DOI:10.1371/journal.pone.0062383.
[17] Matsushime H,Ewen ME,Strom DK,et al. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins[J].Cell,1992,71(2):323-334.DOI:10.1016/0092-8674(92)90360-O.
[18] Ajchenbaum F,Ando K,DeCaprio J,et al. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes[J].J Biol Chem,1993,268(6):4113-4119.
[19] Fracchiolla NS,Pruneri G,Pignataro L,et al. Molecular and immunohistochemical analysis of the bcl-1/Cyclin D1 gene in laryngeal squamous cell carcinomas:correlation of protein expression with lymph node metastases and advanced clinical stage[J].Cancer,1997,79(6):1114-1121.DOI:10.1002/(SICI)1097-0142(19970315)79:6<1114::AID-CNCR9>3.3.CO;2-I. |